AOA 2025: New ways to fix old issues in scleral lenses

News
Video

When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.

Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, provided an insightful overview of the evolution of scleral lens fitting over the past 2 decades. He traced the technological and clinical advancements that have transformed the understanding and application of scleral lenses. When he began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior. Pioneering work by researchers laid foundational groundwork, but significant gaps remained in understanding how to customize lenses for individual patient needs.

A critical observation Michaud shared is that patients consistently prioritize comfort over vision quality. Throughout his 20-year experience, no patient claimed improved vision with scleral lenses, but all emphasized enhanced comfort. This comfort factor has made scleral lenses the primary recommendation for conditions like keratoconus.

Technological advancements have dramatically improved lens fitting and patient monitoring. Michaud highlights 2 particularly transformative technologies: the eye profiler and the aberrometer. The eye profiler allows precise mapping of conjunctiva and sclera, eliminating guesswork and reducing unnecessary patient visits. The aberrometer enables detailed evaluation of high order aberrations, providing concrete data about vision challenges.

The complexity of vision through scleral lenses involves multiple refractive index transitions - from air, to tears, lens, reservoir, and different corneal layers. Modern technology now allows compensation for these complex optical interactions, creating more sophisticated lens designs. However, Michaud emphasized maintaining professional humility. Scleral lenses are not a universal solution, and practitioners must remain open to alternative vision correction methods. The technology offers powerful tools, but also requires significant learning and careful application. The modulated transfer function (MTF) represents another breakthrough, allowing practitioners to quantitatively assess vision quality before and after lens fitting. This enables more precise determination of whether scleral lenses will benefit a specific patient. Ultimately, Michaud's lecture underscored the ongoing evolution of scleral lens technology - a journey of continuous learning, technological innovation, and patient-centered care.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, emphasized that every staff member should play a role in myopia management during his presentation at Optometry's Meeting 2025.
Dr Ashley Tucker Wallace discusses the intersection of pediatric dry eye and myopia control
Karen R. Hoffman, OD, speaks on her AOA 2025 poster, which details a case series on fitting patients with irregular cornea and astigmatism with Zenlens (Bausch + Lomb)
Connecting with colleagues, taking courses, and gathering insight for Optometry Times
Ashley Mills, CEO of The Vision Council, gives insight into the decision to move to a single annual meeting and shares the vision for the meeting going forward.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
© 2025 MJH Life Sciences

All rights reserved.